Journal of Pain Research

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Dysmenorrhea: Therapy and Mechanism", organized by Guest Advisor Dr. Jie Yang (Chengdu University of Traditional Chinese Medicine) in the Journal of Pain Research.

Dysmenorrhea, commonly known as menstrual cramps, is a widespread gynecological disorder that affects a significant number of women worldwide. Despite its high prevalence, effective treatments and a clear understanding of the underlying mechanisms are still lacking. To address this gap in knowledge, we are inviting submissions related to dysmenorrhea for our upcoming Article Collection.

Specifically, we are interested in papers that cover the following topics:
1. Pathophysiology of Dysmenorrhea, including the role of prostaglandins, uterine contractions, and central nervous system sensitization. This topic is crucial in providing a comprehensive understanding of the pathogenesis of dysmenorrhea.
2. Pharmacological Interventions for Dysmenorrhea, such as NSAIDs, hormonal contraceptives, analgesics, and other medications. We are seeking articles that address the evidence, limitations, and side effects supporting the use of these interventions in the management of dysmenorrhea.
3. Non-Pharmacological Interventions for Dysmenorrhea, including exercise, acupuncture, heat therapy, and other alternative therapies. We welcome papers that discuss the evidence supporting the use of these interventions and their potential role in managing dysmenorrhea.
4. Potential Mechanisms for Dysmenorrhea, such as central and peripheral factors, uterine and ovarian blood supply, and other related mechanisms. We also encourage submissions that explore the potential mechanisms underlying therapies aimed at improving ovarian or uterine functions.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submissions is 30 June 2024.

Please submit your manuscript on our website, quoting the promo code LOYEF to indicate that your submission is for consideration in this Article Collection.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “The Future of Pain Medicine: Emerging Technologies, Treatments, and Education” organized by Guest Advisors Dr. Giuliano Lo Bianco, Dr. Christopher Robinson, Dr. Ryan S D'Souza, Dr. Robert Jason Yong, and Dr. Tess Veuthey in the Journal of Pain Research.

"Emerging Technologies, Treatments, and Education" is an in-depth examination of how cutting-edge technologies are revolutionizing pain medicine and education for chronic pain providers and trainees. This Collection explores the transformative impact of emerging technologies such as artificial intelligence, virtual reality, cloud-based technologies, wearables, and novel roles for neuromodulation. By integrating these technologies, pain management and training can be enhanced and patient outcomes improved. Authors are encouraged to contribute their expertise and research findings to advance our understanding of these technologies' role in shaping the future of pain management and education. Whether you are an established researcher or an emerging scholar, this Collection provides a unique opportunity to contribute to the evolving narrative of pain medicine. Join us in exploring the frontiers of technology-driven advancements that promise to transform how we perceive, diagnose, and alleviate pain.

Traditional approaches to pain management face challenges in providing personalized and effective interventions. The integration of artificial intelligence allows for data-driven precision medicine, enabling tailored treatment plans based on individual patient characteristics. Virtual reality offers innovative therapeutic interventions, providing patients an immersive environment to alleviate pain and improve well-being. Cloud-based technologies facilitate seamless data sharing, fostering collaboration among healthcare professionals and researchers globally. Wearables provide real-time monitoring and feedback, enhancing the understanding of pain patterns and enabling timely interventions. Neuromodulation continues to expand its applicability, treating even more conditions than previously considered. Furthermore, pain education must continually evolve to meet the growing arsenal of tools that providers can utilize in their practice. This Collection aims to showcase the significance of these advancements, encouraging researchers to contribute to the ongoing dialogue and propel the field toward a future where technology serves as a powerful ally in the fight against pain.

The Collection invites contributions that span a spectrum of subjects aligned with the scope of our journal.

Subtopics include, but are not limited to:

• Application of artificial intelligence, virtual reality, wearables, and cloud-based technologies in collaboration, monitoring, diagnosis, management, and outcomes.
• Novel applications of neuromodulation such as sensory, motor, or functional restoration.
• Exploration of psychedelics for the management of chronic pain.
• Education reform to accommodate a more efficient and comprehensive training process that equips trainees with the necessary skills to start practice.

Preferred article types for this Collection include original research articles, scoping reviews, systematic reviews and/or meta-analyses, editorials, and perspectives that contribute to the scholarly discourse and foster a deeper understanding of the intersection between emerging technologies and pain management.

Through this diverse array of contributions, we aim to assemble a Collection that not only informs but also sparks dialogue and innovation in the field.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submissions is 1 September 2024.

Please submit your manuscript on our website, quoting the promo code MYDFN to indicate that your submission is for consideration in this Article Collection.

Please do not hesitate to contact Commissioning Editor Alice Soteriou at [email protected] should you have any questions with regards to your submission.

Guest Advisors

Dr. Giuliano Lo Bianco, MD, PhD, FIPP, EDPM, is a distinguished expert in Anesthesia and Pain Therapy, specializing in percutaneous fluoro/ultrasound-guided interventions. With a commitment to advancing pain therapy, he collaborates with leading experts globally and holds key positions at Fondazione G. Giglio di Cefalù since 2020, serving as the Head of the Operational Unit for Analgesia and Percutaneous Surgery. Dr. Lo Bianco is an esteemed educator, sharing his expertise through lectures at the University of Palermo and the University of Pavia, contributing to the development of pain therapy programs. His dedication to advancing pain medicine and research makes a lasting impact on healthcare and well-being.

Dr. Christopher Robinson, MD, PhD is a resident physician-scientist at Harvard Medical School-BIDMC and will be doing his chronic pain fellowship at Brigham and Women's Hospital. Dr. Robinson did his MD, PhD in stem cell biology in the lab of Dr. Shuibing Chen at the Weill Cornell Medicine/Rockefeller University/Sloan-Kettering Tri-Institutional MD-PhD Program. His team leadership experience from running a startup during his PhD allowed him and his PhD team including the 2020 Nobel Prize winner in medicine, Dr. Charles Rice, to discover a new anti-viral drug targeting Zika virus during the epidemic. Prior to his MD/PhD, he completed his undergraduate studies at Georgetown University in Washington DC. Now, his chronic pain research team, consisting of members across the globe, work together to accomplish science and medicine in a whole different way utilizing everyone's skillsets across all specialties from machine learners (artificial intelligence developers) to physician-scientists to ethicists to bring education and research to all while keeping the patient at the center.

Dr. Ryan S D’Souza is an interventional pain physician and anesthesiologist in Mayo Clinic. He was ranked in the top 1% of physicians in the country based on national clinical knowledge testing required to graduate from residency and fellowship. Dr. D'Souza is currently an Associate Professor of Anesthesiology and Perioperative Medicine at Mayo Clinic (Rochester). His clinical and research interests include spinal cord stimulation, peripheral nerve stimulation, fibromyalgia, evidence appraisal, and education. He has lectured both national and internationally and has published extensively in neuromodulation and chronic pain.

Dr. Robert Jason Yong earned his medical degree and Master of Business Administration at Baylor College of Medicine in Houston. He completed his internship in General Surgery at Beth Israel Deaconess Medical Center in Boston and completed his residency in Anesthesiology at Brigham and Women’s Hospital in Boston, where he was named Chief Resident, an FAER Scholar and a Distinguished Resident. Dr. Young completed his fellowship in Pain Medicine at Brigham and Women’s Hospital in Boston. He completed his Bachelor of Arts in Biology at the University of Texas at Austin.

Dr. Tess Veuthey MD/PhD is a neurology resident at Stanford interested in neural engineering, chronic pain, psychedelics, and health disparities. Her PhD examined neural representations of behavior in rodents learning motor skills and brain-machine interface tasks. She is looking to bring tools from those fields into the study of chronic pain and its treatment. Dr. Veuthey aims to integrate neuromodulation and psychedelics to collaboratively develop safe, effective treatments for neuropsychiatric conditions both within and outside of formal medical contexts. She has been supported by a Fulbright Fellowship, National Defense Science and Engineering Graduate Fellowship (NDSEG), North American Neuromodulation Society Diversity and Outreach Committee Pipeline Fellowship Grant, and NINDS R25.

View all papers in this article collection